chromocarb diethylamine has been researched along with Hematologic Malignancies in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Buzzeo, MP; Dunbar, EM; Levine, JB; Meier-Kriesche, HU; Reddy, V; Schold, JD | 1 |
1 trial(s) available for chromocarb diethylamine and Hematologic Malignancies
| Article | Year |
|---|---|
The relationship between circulating natural killer cells after reduced intensity conditioning hematopoietic stem cell transplantation and relapse-free survival and graft-versus-host disease.
Topics: Adult; Antilymphocyte Serum; Blood Cells; Chromones; Diethylamines; Disease-Free Survival; Drug Combinations; Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Killer Cells, Natural; Lymphocyte Count; Male; Middle Aged; Predictive Value of Tests; Prognosis; Prospective Studies; Transplantation Conditioning; Whole-Body Irradiation | 2008 |